CyTOF and O-Link Assessment in the NCI COVID-19 in Cancer Patients Study(NCCAPS)
Awarded Limited / Sole Source Justification Posted
Not the latest version. See the latest pre-solicitation from .
- Solicitation number
- 75N91021C00003-2
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N91021C00003 Federal contract award
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Cancer Institute issued a modification to extend an existing contract with an unknown vendor by 12 months to continue CyTOF and O-Link assessment services in support of the NCI COVID-19 in Cancer Patients Study. The justification cites the vendor's specialized expertise and institutional knowledge of previously delivered CyTOF and O-Link assessment services as rationale for a noncompetitive award modification. The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded the sole source modification on December 20, 2021 for an unknown value to continue providing specialized services to the agency.
Notice text
The purpose of this modification is to extend the Period of Performance by 12 months. This notice is to provide a redacted version of the Justification for Other Than Full and Open Competition.
Awarded contract 75N91021C00003 to unknown vendor for unknown amount on 2021-12-20.
Files
| File | Type | Posted |
|---|---|---|
| 75N91021C00003 - Justification and Approval - redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| CyTOF and O-Link Assessment in the NCI COVID-19 in Cancer Patients Study(NCCAPS) | Limited / Sole Source Justification | |
| CyTOF and O-Link Assessment in the NCI COVID-19 in Cancer Patients Study(NCCAPS) | Pre-Solicitation | |
| This notice | Limited / Sole Source Justification | |
| CyTOF and O-Link Assessment in the NCI COVID-19 in Cancer Patients Study(NCCAPS) | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity